Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Benzinga Rankings give you vital metrics on any stock – anytime.
Explore Gain Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for GANX.
You can purchase shares of Gain Therapeutics (NASDAQ:GANX) through any online brokerage.
Other companies in Gain Therapeutics’s space includes: Inozyme Pharma (NASDAQ:INZY), Burning Rock Biotech (NASDAQ:BNR), Adicet Bio (NASDAQ:ACET), PMV Pharma (NASDAQ:PMVP) and Cue Biopharma (NASDAQ:CUE).
Gain Therapeutics has a consensus price target of $8.33.
The stock price for Gain Therapeutics (NASDAQ: GANX) is $2.39 last updated March 18, 2025 at 7:22 AM EDT.
There are no upcoming dividends for Gain Therapeutics.
Gain Therapeutics’s Q1 earnings are confirmed for Tuesday, May 13, 2025.
There is no upcoming split for Gain Therapeutics.
Gain Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.